RxSight, Inc.
RXST
DELAYED 1 MONTH
6 insider filings · Latest: Jul 24, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Jul 25 12:07 AM | Aziz MottiwalaDirector, President and CEO | Grant/Award | 2,883,424 | $5.19 | 571,286(D) | View → |
| Feb 28, 2026 | Mar 4 1:24 AM | Mark WilterdingChief Financial Officer | Option Exercise | 20,441 | — | 143,087(D) | View → |
| Feb 28, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Option Exercise | 6,261 | — | 2,500(D) | View → |
| Feb 27, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:21 AM | Ilya GoldshlegerChief Operating Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:20 AM | Eric WeinbergExhibit 24 - Power of Attorney Chief Business Development Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:19 AM | Ronald M Kurtz MDDirector, President & CEO | Grant/Award | 80,545 | — | 80,545(D) | View → |